Symptom-centric view
Application site irritation
Substances reporting Application site irritation disproportionately — ranked by ROR.
showing 1 of 1
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
minoxidil Rogaine · Loniten | 62.1 [58.7–65.7] | 1,401 | glp-1 | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).